Cargando…
MYC及BCL-2蛋白双表达对弥漫大B细胞淋巴瘤患者预后影响:倾向性评分匹配分析
OBJECTIVE: We investigated the impact of MYC/BCL-2 protein co-expression on the prognosis of diffuse large B-cell lymphoma(DLBCL)patients and observed whether double expression(DE)remains an independent poor prognostic factor in DLBCL after the addition of therapeutic factors such as DA-EPOCH-R, cen...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980659/ https://www.ncbi.nlm.nih.gov/pubmed/35231992 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.01.009 |
Ejemplares similares
-
P53及BCL2蛋白在双表达弥漫大B细胞淋巴瘤中的预后判断价值
Publicado: (2019) -
弥漫大B细胞淋巴瘤患者蛋白表达检测的预后意义
Publicado: (2017) -
166例双表达弥漫大B细胞淋巴瘤临床特征与预后分析
Publicado: (2022) -
单孔与单操作孔胸腔镜下胸腺瘤切除术的临床疗效比较:一项倾向性评分匹配研究
Publicado: (2022) -
不同分层方法对早期弥漫大B细胞淋巴瘤预后价值的比较
Publicado: (2016)